ARID1A mutations are common in ovarian clear cell carcinomas (OCCCs) and endometrioid carcinomas (OECs), leading to loss of ARID1A protein expression and driving ovarian cancer progression [106,107]. This evidence concerns the gene ARID1A and ovarian clear cell cancer.